

Anti-Glypican-3 Antibody Y300207 by abm targets GPC3, a glycosyl phosphatidylinositol-anchored proteoglycan overexpressed in hepatocellular carcinoma and used as a key IHC marker to distinguish HCC from benign hepatic lesions. Available from MBP, a registered vendor at leading US research institutions.